` EVGN (Evogene Ltd) vs S&P 500 Comparison - Alpha Spread

EVGN
vs
S&P 500

Over the past 12 months, EVGN has underperformed S&P 500, delivering a return of -28% compared to the S&P 500's +19% growth.

Stocks Performance
EVGN vs S&P 500

Loading
EVGN
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
EVGN vs S&P 500

Performance Gap Between EVGN and GSPC
HIDDEN
Show

Performance By Year
EVGN vs S&P 500

Loading
EVGN
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Evogene Ltd vs Peers

S&P 500
EVGN
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Evogene Ltd
Glance View

Market Cap
9.7m USD
Industry
Biotechnology

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

EVGN Intrinsic Value
HIDDEN
Show
Back to Top